Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Z26
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,094
Award facts
- Contract value 100% obligated
- $15,094.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,094.28 to AmerisourceBergen Drug Corp for the supply of Nurtec ODT 75 mg tablets (8-count units) on January 21, 2026, with an ultimate completion date of January 22, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award supports the federal government's pharmaceutical supply needs, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031, which serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally.
AmerisourceBergen, through its parent Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement functions, particularly for the Defense Health Agency and military treatment facilities. The Nurtec ODT product supplied under this order is a migraine treatment medication, reflecting the company's extensive portfolio covering multiple therapeutic domains including neurological treatments, diabetes medications, pain management, and specialty pharmaceuticals. The competitive nature of this award and the company's demonstrated capability in fulfilling substantial federal pharmaceutical contracts underscore its role as a key vendor in supporting military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9Z26?
SPE2DR26F9Z26 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9Z26 worth?
The government has obligated $15,094 on SPE2DR26F9Z26.
Is contract SPE2DR26F9Z26 an order under another contract?
Yes. SPE2DR26F9Z26 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Z26 competed?
The extent of competition for SPE2DR26F9Z26 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award